Herein we summarise the rationale and available evidence in support for combination therapy
Differential effects of GLP-1 receptor agonists on components of dysglycaemia in individuals with type 2 diabetes mellitus
DNA Repair It activates enzymes called PARPs, which are involved in repairing damaged DNA
The principle of "start low, go slow" applies with particular force here
These challenges were ultimately overcome through molecular modification, long-acting formulations, and a more sophisticated understanding of receptor pharmacology, including biased agonism and doseexposure relationships (Mller et al., 2019)
In controlled research settings, Epithalon-based peptides have been studied for their influence on telomerase activity, circadian rhythm regulation, and gene expression modulation